Sarissa Capital Master Fund Ii Lp - Net Worth and Insider Trading

Sarissa Capital Master Fund Ii Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sarissa Capital Master Fund Ii Lp owns 2 companies in total, including Regulus Therapeutics Inc (RGLS) , and Iterum Therapeutics PLC (ITRM) .

Click here to see the complete history of Sarissa Capital Master Fund Ii Lp’s form 4 insider trades.

Insider Ownership Summary of Sarissa Capital Master Fund Ii Lp

Ticker Comapny Transaction Date Type of Owner
RGLS Regulus Therapeutics Inc 2020-04-01 10 percent owner
ITRM Iterum Therapeutics PLC 2021-02-11 10 percent owner

Sarissa Capital Master Fund Ii Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sarissa Capital Master Fund Ii Lp Ownership Network

Ownership Network List of Sarissa Capital Master Fund Ii Lp

No Data

Ownership Network Relation of Sarissa Capital Master Fund Ii Lp


Sarissa Capital Master Fund Ii Lp Owned Company Details

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Sarissa Capital Master Fund Ii Lp is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and Chief Operating Officer Joseph P Hagan .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Sarissa Capital Master Fund Ii Lp made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regulus Therapeutics Inc Insider Transactions

No Available Data

Sarissa Capital Master Fund Ii Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Sarissa Capital Master Fund Ii Lp. You might contact Sarissa Capital Master Fund Ii Lp via mailing address: C/o Sarissa Capital Management Lp, 660 Steamboat Road, 3rd Floor, Greenwich Ct 06830.

Discussions on Sarissa Capital Master Fund Ii Lp

No discussions yet.